Cargando…
Opening up new fronts in the fight against cholesterol
An unexpected connection between a secretory protein called PCSK9 and Sec24A, a well known protein-transport protein, could lead to the development of novel treatments for patients with high levels of low-density lipoproteins in their blood.
Autores principales: | DeBose-Boyd, Russell A, Horton, Jay D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622229/ https://www.ncbi.nlm.nih.gov/pubmed/23580362 http://dx.doi.org/10.7554/eLife.00663 |
Ejemplares similares
-
The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
por: Schumacher, Marc M, et al.
Publicado: (2015) -
Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1
por: Elsabrouty, Rania, et al.
Publicado: (2021) -
Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis
por: Das, Akash, et al.
Publicado: (2014) -
Structures of dimeric human NPC1L1 provide insight into mechanisms for cholesterol absorption
por: Long, Tao, et al.
Publicado: (2021) -
Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export
por: Li, Jian, et al.
Publicado: (2016)